Givaudan will acquire Alderys to 'subvert' raw material production

On May 28, Givaudan announced on the official website that it will acquire French innovative biotechnology company Alderys, in order to expand its bioengineering technology strength and strengthen sustainable and disruptive biotechnology processes.

Alderys was founded in 2009 and is headquartered in Orsay, France. The company is dedicated to the development of innovative bioengineering approaches to produce high-value compounds from renewable raw materials. Its projects are designed to serve industries such as chemicals, cosmetics and nutrition.

 Maurizio Volpi, President of the Fragrance Division at Givaudan, said: "The acquisition of Alderys is in line with our long-term strategy for the Active Beauty business. Specifically, their bio Technical expertise perfectly complements our daily fragrance and active beauty businesses. Thanks to their powerful bioengineering research and development platform, we can expand our natural, biologically derived product portfolio. This will be our driving force for cosmetic active ingredients and other businesses A new tool for development and innovation. "

 Dominique Thomas, CEO of Alderys, added: "We are very proud to join Givaudan and contribute to our 10-year successful bioengineering platform. We firmly believe that this is our expansion of our scientific expertise to Good opportunities in the fields of beauty, daily flavors and edible flavors. "

 Laurent Bourdeau, head of Givaudan ’s active beauty business, also said: “Alderys has a strong historical background in designing and producing innovative biological pathways for environmentally friendly raw materials. The essential."

 Although the terms of the transaction have not been disclosed, on the basis of assumptions, Alderys' business can increase Givaudan's 2019 results by 3 million euros in revenue. The acquisition plan is still subject to formal approval by relevant regulatory agencies, and the transaction is expected to be completed in the second quarter of 2020.